We next established a patient-derived xenograft (PDX) model using one of the PPM1D mutated t-AML samples and observed that the engrafted leukemic cells indeed carried a clonal PPM1D mutation (VAF >0.4). This evidence concerns the gene PPM1D and acute myeloid leukemia.